ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

CERT Certara Inc

17,60
-0,01 (-0,06%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Certara Inc CERT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,01 -0,06% 17,60 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
17,93 17,45 17,94 17,60 17,61
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
16/4/202414:00GLOBECertara Launches Cloud Platform to Further Unify its..
09/4/202422:15GLOBECertara to Report First Quarter 2024 Financial Results on..
06/3/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:26EDGAR2Form 144 - Report of proposed sale of securities
29/2/202422:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202422:21EDGAR2Form 8-K - Current report
29/2/202422:10GLOBECertara Reports Fourth Quarter 2023 Financial Results
21/2/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202418:25EDGAR2Form 144 - Report of proposed sale of securities
14/2/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202423:14EDGAR2Form 144 - Report of proposed sale of securities
01/2/202422:30GLOBECertara to Report Fourth Quarter and Full Year 2023..
28/12/202300:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202318:22EDGAR2Form 144 - Report of proposed sale of securities
13/12/202322:30GLOBECertara Acquires Applied BioMath Expanding Its Biosimulation..
21/11/202322:30GLOBECertara introduces Simcyp™ Biopharmaceutics software to..
08/11/202322:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:16EDGAR2Form 8-K - Current report
08/11/202322:10GLOBECertara Reports Third Quarter 2023 Financial Results
11/10/202322:15GLOBECertara to Report Third Quarter 2023 Financial Results on..
06/10/202323:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202314:15GLOBECertara Announces 300th Regulatory Submission Milestone..
29/8/202322:15GLOBECertara to Participate in Upcoming Investor Conferences
29/8/202314:15GLOBECertara Simcyp™ Group Awarded Two New Grants from US FDA
09/8/202322:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:15GLOBECertara Reports Second Quarter 2023 Financial Results
09/8/202322:11EDGAR2Form 8-K - Current report
04/8/202303:00BWCertara collaborates with Korea Institute of Toxicology to..
02/8/202322:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202322:30GLOBECertara to Report Second Quarter 2023 Financial Results on..
03/7/202323:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/6/202322:15GLOBECertara to Participate in the Jefferies Global Healthcare..
08/5/202322:15GLOBECertara Reports First Quarter 2023 Financial Results

Dernières Valeurs Consultées

Delayed Upgrade Clock